東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Spherical crystallization as a new p...

Kawashima, Yoshiaki.

FindBook

Google Book

Amazon

博客來

Spherical crystallization as a new platform for particle design engineering

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Spherical crystallization as a new platform for particle design engineering/ by Yoshiaki Kawashima.
作者:	Kawashima, Yoshiaki.
出版者:	Singapore :Springer Singapore : : 2019.,
面頁冊數:	xvii, 118 p. :ill., digital ;24 cm.
內容註:	Introduction -- Concept of spherical crystallization -- Paradigm shifted pharmaceutical process introduced by spherical crystallization -- Particulate-design platform developed by the Advanced Spherical Crystallization System -- Development of Novel Microsphere and Microballoon DDS by Polymeric Spherical Crystallization -- Development of PLGA Nanopsphere for Drug Delivery System (DDS) Prepared by Polymeric Spherical Crystallization -- Application of PLGA NSs to cosmetics -- Future perspectives of PLGA nanospheres for advanced DDSs and continuous preparation systems for spherical crystallizers.
Contained By:	Springer eBooks
標題:	Crystallization. -
電子資源:	https://doi.org/10.1007/978-981-13-6786-1
ISBN:	9789811367861

Spherical crystallization as a new platform for particle design engineering
Kawashima, Yoshiaki.

Spherical crystallization as a new platform for particle design engineering[electronic resource] /by Yoshiaki Kawashima. - Singapore :Springer Singapore :2019. - xvii, 118 p. :ill., digital ;24 cm.

Introduction -- Concept of spherical crystallization -- Paradigm shifted pharmaceutical process introduced by spherical crystallization -- Particulate-design platform developed by the Advanced Spherical Crystallization System -- Development of Novel Microsphere and Microballoon DDS by Polymeric Spherical Crystallization -- Development of PLGA Nanopsphere for Drug Delivery System (DDS) Prepared by Polymeric Spherical Crystallization -- Application of PLGA NSs to cosmetics -- Future perspectives of PLGA nanospheres for advanced DDSs and continuous preparation systems for spherical crystallizers.

This book describes the principles and applications of the spherical crystallization technique, from the standpoint of its inventor. After an introduction on the history of particle design engineering and nanotechnology, the concept of spherical crystallization itself is clearly explained. Attention then turns to the application of spherical crystallization in pharmaceutical processes. It is explained how the technique can provide physicochemical properties suitable for direct tableting of active pharmaceutical ingredients and how it has enabled the development of a novel particulate design platform from single to complex system. Subsequent chapters describe the roles of polymeric spherical crystallization in the preparation of novel microspheres, microballoons for drug delivery systems (DDS) and the development of biocompatible and biodegradable poly(D,L-lactide-co-glycolide) (PLGA) nanospheres. The various applications of PLGA nanospheres composite within oral-, pulmonary-, transdermal DDS and cosmetics are fully discussed. Finally, future perspectives are presented on use of the technology in the design and industrial-scale manufacture of new drug delivery systems, highlighting how a continuous pharmaceutical process that meets US Food and Drug Administration quality requirements should soon be introduced.

ISBN: 9789811367861

Standard No.: 10.1007/978-981-13-6786-1doiSubjects--Topical Terms:

608799
Crystallization.

LC Class. No.: RS192 / .K393 2019

Dewey Class. No.: 615.19

Spherical crystallization as a new platform for particle design engineering
LDR:02931nmm a2200325 a 4500 001 2191076
003 DE-He213
005 20191015171130.0
006 m d
007 cr nn 008maaau
008 200504s2019 si s 0 eng d
020 $a 9789811367861 $q (electronic bk.)
020 $a 9789811367854 $q (paper)
024 7 $a 10.1007/978-981-13-6786-1 $2 doi
035 $a 978-981-13-6786-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RS192 $b .K393 2019
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a TDC $2 thema
082 0 4 $a 615.19 $2 23
090 $a RS192 $b .K22 2019
100 1 $a Kawashima, Yoshiaki. $3 3410135
245 1 0 $a Spherical crystallization as a new platform for particle design engineering $h [electronic resource] / $c by Yoshiaki Kawashima.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2019.
300 $a xvii, 118 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction -- Concept of spherical crystallization -- Paradigm shifted pharmaceutical process introduced by spherical crystallization -- Particulate-design platform developed by the Advanced Spherical Crystallization System -- Development of Novel Microsphere and Microballoon DDS by Polymeric Spherical Crystallization -- Development of PLGA Nanopsphere for Drug Delivery System (DDS) Prepared by Polymeric Spherical Crystallization -- Application of PLGA NSs to cosmetics -- Future perspectives of PLGA nanospheres for advanced DDSs and continuous preparation systems for spherical crystallizers.
520 $a This book describes the principles and applications of the spherical crystallization technique, from the standpoint of its inventor. After an introduction on the history of particle design engineering and nanotechnology, the concept of spherical crystallization itself is clearly explained. Attention then turns to the application of spherical crystallization in pharmaceutical processes. It is explained how the technique can provide physicochemical properties suitable for direct tableting of active pharmaceutical ingredients and how it has enabled the development of a novel particulate design platform from single to complex system. Subsequent chapters describe the roles of polymeric spherical crystallization in the preparation of novel microspheres, microballoons for drug delivery systems (DDS) and the development of biocompatible and biodegradable poly(D,L-lactide-co-glycolide) (PLGA) nanospheres. The various applications of PLGA nanospheres composite within oral-, pulmonary-, transdermal DDS and cosmetics are fully discussed. Finally, future perspectives are presented on use of the technology in the design and industrial-scale manufacture of new drug delivery systems, highlighting how a continuous pharmaceutical process that meets US Food and Drug Administration quality requirements should soon be introduced.
650 0 $a Crystallization. $3 608799
650 0 $a Pharmaceutical technology. $3 562441
650 1 4 $a Pharmaceutical Sciences/Technology. $3 1001579
650 2 4 $a Biomedical Engineering/Biotechnology. $3 2162071
650 2 4 $a Biochemical Engineering. $3 892423
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-981-13-6786-1
950 $a Biomedical and Life Sciences (Springer-11642)